For research use only. Not for therapeutic Use.
AMG-1(Cat No.:I021957)is a small molecule compound that has been investigated for its potential in cancer therapy. It belongs to a class of inhibitors that target specific signaling pathways involved in tumor growth and progression. AMG-1 is primarily studied for its ability to modulate the immune system and inhibit the proliferation of cancer cells. Through its action on specific molecular targets, AMG-1 shows promise in preclinical studies for improving the effectiveness of existing cancer treatments, especially in combination with immunotherapies. However, further research is needed to assess its safety and efficacy in clinical settings.
Catalog Number | I021957 |
CAS Number | 903591-53-7 |
Synonyms | AMG1; AMG 1; AMG-1 |
Molecular Formula | C18H9ClF5N3O |
Purity | 98% |
Solubility | Soluble in DMSO |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
IUPAC Name | N-[5-[2-chloro-5-(trifluoromethyl)phenyl]pyrazin-2-yl]-2,6-difluorobenzamide |
InChI | InChI=1S/C18H9ClF5N3O/c19-11-5-4-9(18(22,23)24)6-10(11)14-7-26-15(8-25-14)27-17(28)16-12(20)2-1-3-13(16)21/h1-8H,(H,26,27,28) |
InChIKey | LWJKSVUJZBEXCH-UHFFFAOYSA-N |
SMILES | C1=CC(=C(C(=C1)F)C(=O)NC2=NC=C(N=C2)C3=C(C=CC(=C3)C(F)(F)F)Cl)F |